Impact of the Generic Valsartan Recall in Alberta, Canada.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2020.02.034
Abstract: After N-nitrosodimethylamine, a potential carcinogen, was detected in valsartan supplied by Zhejiang Huahai Pharmaceuticals (Zhejiang, China), Health Canada issued a voluntary recall notice on July 9, 2018, for 28 generic valsartan preparations ([1][1]). The impact… read more here.
Keywords: impact generic; generic valsartan; recall; recall alberta ... See more keywords